vs

Side-by-side financial comparison of Silvercrest Asset Management Group Inc. (SAMG) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

TREACE MEDICAL CONCEPTS, INC. is the larger business by last-quarter revenue ($62.5M vs $32.0M, roughly 2.0× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -15.0%, a 14.7% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -9.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-10.4M). Over the past eight quarters, TREACE MEDICAL CONCEPTS, INC.'s revenue compounded faster (10.6% CAGR vs 2.7%).

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

SAMG vs TMCI — Head-to-Head

Bigger by revenue
TMCI
TMCI
2.0× larger
TMCI
$62.5M
$32.0M
SAMG
Growing faster (revenue YoY)
SAMG
SAMG
+9.0% gap
SAMG
-0.0%
-9.0%
TMCI
Higher net margin
SAMG
SAMG
14.7% more per $
SAMG
-0.4%
-15.0%
TMCI
More free cash flow
SAMG
SAMG
$25.4M more FCF
SAMG
$15.0M
$-10.4M
TMCI
Faster 2-yr revenue CAGR
TMCI
TMCI
Annualised
TMCI
10.6%
2.7%
SAMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SAMG
SAMG
TMCI
TMCI
Revenue
$32.0M
$62.5M
Net Profit
$-120.0K
$-9.4M
Gross Margin
80.6%
Operating Margin
-2.8%
-9.5%
Net Margin
-0.4%
-15.0%
Revenue YoY
-0.0%
-9.0%
Net Profit YoY
-107.4%
-1775.0%
EPS (diluted)
$0.02
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SAMG
SAMG
TMCI
TMCI
Q4 25
$32.0M
$62.5M
Q3 25
$31.3M
$50.2M
Q2 25
$30.7M
$47.4M
Q1 25
$31.4M
$52.6M
Q4 24
$32.0M
$68.7M
Q3 24
$30.4M
$45.1M
Q2 24
$31.0M
$44.5M
Q1 24
$30.3M
$51.1M
Net Profit
SAMG
SAMG
TMCI
TMCI
Q4 25
$-120.0K
$-9.4M
Q3 25
$618.0K
$-16.3M
Q2 25
$1.9M
$-17.4M
Q1 25
$2.5M
$-15.9M
Q4 24
$1.6M
$-501.0K
Q3 24
$2.3M
$-15.4M
Q2 24
$2.7M
$-21.2M
Q1 24
$3.0M
$-18.7M
Gross Margin
SAMG
SAMG
TMCI
TMCI
Q4 25
80.6%
Q3 25
79.1%
Q2 25
79.7%
Q1 25
79.7%
Q4 24
80.7%
Q3 24
80.1%
Q2 24
80.2%
Q1 24
80.2%
Operating Margin
SAMG
SAMG
TMCI
TMCI
Q4 25
-2.8%
-9.5%
Q3 25
4.3%
-31.2%
Q2 25
13.2%
-35.8%
Q1 25
15.4%
-29.6%
Q4 24
6.1%
-0.3%
Q3 24
14.6%
-33.6%
Q2 24
17.1%
-48.1%
Q1 24
19.5%
-37.1%
Net Margin
SAMG
SAMG
TMCI
TMCI
Q4 25
-0.4%
-15.0%
Q3 25
2.0%
-32.4%
Q2 25
6.3%
-36.7%
Q1 25
7.9%
-30.3%
Q4 24
5.1%
-0.7%
Q3 24
7.4%
-34.1%
Q2 24
8.6%
-47.7%
Q1 24
9.9%
-36.5%
EPS (diluted)
SAMG
SAMG
TMCI
TMCI
Q4 25
$0.02
$-0.14
Q3 25
$0.07
$-0.26
Q2 25
$0.21
$-0.28
Q1 25
$0.26
$-0.25
Q4 24
$0.16
$-0.01
Q3 24
$0.24
$-0.25
Q2 24
$0.28
$-0.34
Q1 24
$0.32
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SAMG
SAMG
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$44.1M
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$50.3M
$87.3M
Total Assets
$166.6M
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SAMG
SAMG
TMCI
TMCI
Q4 25
$44.1M
$48.4M
Q3 25
$36.1M
$57.4M
Q2 25
$30.0M
$69.3M
Q1 25
$36.3M
$76.1M
Q4 24
$68.6M
$75.7M
Q3 24
$58.1M
$82.8M
Q2 24
$49.9M
$95.0M
Q1 24
$39.7M
$110.0M
Total Debt
SAMG
SAMG
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
SAMG
SAMG
TMCI
TMCI
Q4 25
$50.3M
$87.3M
Q3 25
$58.9M
$89.2M
Q2 25
$64.6M
$97.6M
Q1 25
$80.0M
$105.3M
Q4 24
$80.7M
$112.9M
Q3 24
$84.6M
$104.9M
Q2 24
$85.3M
$112.1M
Q1 24
$83.9M
$126.4M
Total Assets
SAMG
SAMG
TMCI
TMCI
Q4 25
$166.6M
$190.6M
Q3 25
$157.6M
$196.6M
Q2 25
$152.7M
$206.4M
Q1 25
$159.9M
$205.8M
Q4 24
$194.4M
$217.1M
Q3 24
$184.2M
$212.9M
Q2 24
$177.6M
$226.1M
Q1 24
$170.2M
$242.7M
Debt / Equity
SAMG
SAMG
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SAMG
SAMG
TMCI
TMCI
Operating Cash FlowLast quarter
$18.6M
$-8.0M
Free Cash FlowOCF − Capex
$15.0M
$-10.4M
FCF MarginFCF / Revenue
46.9%
-16.7%
Capex IntensityCapex / Revenue
11.4%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.0M
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SAMG
SAMG
TMCI
TMCI
Q4 25
$18.6M
$-8.0M
Q3 25
$14.6M
$-9.1M
Q2 25
$13.8M
$-3.0M
Q1 25
$-24.7M
$4.2M
Q4 24
$21.6M
$-4.2M
Q3 24
$13.3M
$-11.8M
Q2 24
$16.0M
$-13.9M
Q1 24
$-24.1M
$-7.2M
Free Cash Flow
SAMG
SAMG
TMCI
TMCI
Q4 25
$15.0M
$-10.4M
Q3 25
$13.8M
$-11.9M
Q2 25
$13.4M
$-7.8M
Q1 25
$-25.1M
$655.0K
Q4 24
$19.9M
$-7.3M
Q3 24
$12.9M
$-14.7M
Q2 24
$15.6M
$-15.6M
Q1 24
$-24.7M
$-11.1M
FCF Margin
SAMG
SAMG
TMCI
TMCI
Q4 25
46.9%
-16.7%
Q3 25
44.1%
-23.7%
Q2 25
43.6%
-16.5%
Q1 25
-80.0%
1.2%
Q4 24
62.2%
-10.6%
Q3 24
42.4%
-32.6%
Q2 24
50.4%
-35.2%
Q1 24
-81.6%
-21.8%
Capex Intensity
SAMG
SAMG
TMCI
TMCI
Q4 25
11.4%
3.8%
Q3 25
2.6%
5.6%
Q2 25
1.5%
10.1%
Q1 25
1.3%
6.7%
Q4 24
5.3%
4.5%
Q3 24
1.2%
6.4%
Q2 24
1.1%
3.9%
Q1 24
2.0%
7.7%
Cash Conversion
SAMG
SAMG
TMCI
TMCI
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

TMCI
TMCI

Segment breakdown not available.

Related Comparisons